rss
Thorax 2002;57:1010-1014 doi:10.1136/thorax.57.12.1010
  • Original articles

Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis

  1. T McWilliams,
  2. A U Wells,
  3. A C Harrison,
  4. S Lindstrom,
  5. R J Cameron,
  6. E Foskin
  1. Respiratory Services, Green Lane Hospital, Auckland, New Zealand
  1. Correspondence to:
    Dr A Harrison, Respiratory Services, Green Lane Hospital, Auckland, New Zealand;
    adrianh{at}adhb.govt.nz
  • Accepted 12 August 2002
  • Revised 1 July 2002

Abstract

Background: Previous studies suggest that bronchoscopy and a single induced sputum sample are equally effective for diagnosing pulmonary tuberculosis.

Methods: In a prospective study of subjects with possibly active pulmonary tuberculosis, the diagnostic yield of three induced sputum tests was compared with that of bronchoscopy. Subjects either produced no sputum or (acid fast) smear negative sputum. Bronchoscopy was only performed if at least two induced sputum samples were smear negative.

Results: Of 129 subjects who completed all tests, 27 (21%) had smear negative and culture positive specimens, 14 (52%) on bronchoscopy and 26 (96%) on induced sputum (p<0.005). One patient was culture positive on bronchoscopy alone compared with 13 on induced sputum alone; 13 were culture positive on both tests. Induced sputum positivity was strikingly more prevalent when chest radiographic appearances showed any features of active tuberculosis (20/63, 32%) than when appearances suggested inactivity (1/44, 2%; p<0.005). Induced sputum costs were about one third those of bronchoscopy, and the ratio of costs of the two tests per case of tuberculosis diagnosed could be as much as 1:6.

Conclusions: In subjects investigated for possibly active or inactive tuberculosis who produce no sputum or have smear negative sputum, the most cost effective strategy is to perform three induced sputum tests without bronchoscopy. Induced sputum testing carries a high risk of nosocomial tuberculosis unless performed in respiratory isolation conditions. The cost benefits shown could be lost if risk management measures are not observed.

Footnotes

  • Supported by a grant from the Asser Trust, Auckland, and the Auckland Chest and Tuberculosis Association, Auckland, New Zealand.

  • Conflicts of interest: none.

This Article

Services

  1. Request permissions

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Free archive
The full back archive is now available for Thorax. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.